Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director departure
Appointed director
CC transcript
Upcoming conference date
Auditor change
Appointed CFO
PONIARD PHARMACEUTICALS, INC. (PARD) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/02/2012 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
04/02/2012 8-K Quarterly results
03/30/2012 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/26/2012 EFFECT Form EFFECT - Notice of Effectiveness
03/23/2012 RW Form RW - Registration Withdrawal Request
03/22/2012 POS AM Form POS AM - Post-Effective amendments for registration statement
02/23/2012 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
01/05/2012 8-K Form 8-K - Current report
12/23/2011 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Merger Termination Agreement between Poniard Pharmaceuticals, Inc. and Allozyne, Inc.",
"Poniard Pharmaceuticals and Allozyne Terminate Planned Merger"
11/22/2011 8-K Form 8-K - Current report
11/18/2011 425 Form 425 - Prospectuses and communications, business combinations
11/10/2011 425 Form 425 - Prospectuses and communications, business combinations
11/09/2011 425 Form 425 - Prospectuses and communications, business combinations
11/04/2011 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/02/2011 8-K Form 8-K - Current report
10/28/2011 425 Form 425 - Prospectuses and communications, business combinations
10/28/2011 10-Q Quarterly Report for the period ended September 30, 2011
10/28/2011 425 Form 425 - Prospectuses and communications, business combinations
10/21/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/07/2011 425 Form 425 - Prospectuses and communications, business combinations
10/06/2011 S-4/A Form S-4 - Registration of securities, business combinations [amend]
09/07/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Poniard Pharmaceuticals Receives Favorable NASDAQ Decision for Continued Listing of Company Shares"
09/06/2011 S-4/A Form S-4 - Registration of securities, business combinations [amend]
09/06/2011 425 Form 425 - Prospectuses and communications, business combinations
08/16/2011 8-K Form 8-K - Current report
08/12/2011 10-Q Quarterly Report for the period ended June 30, 2011
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy